Literature DB >> 11396746

Fatal rebleeding following coil embolization of cerebral aneurysms: the role of long-term systemic anticoagulation.

G Sinson1, L J Bagley, E S Flamm, R W Hurst.   

Abstract

Embolization of cerebral aneurysms has become a common technique. Its impact on subsequent medical management of the patient is not well known. We report two patients who presented in a poor neurological grade after subarachnoid hemorrhage from posterior communicating artery aneurysms. Both were treated by coil embolization and both developed subclavian vein thrombosis, requiring systemic anticoagulation, initiated 11 and 21 days after embolization, respectively. Both developed a large, fatal intracranial hemorrhage adjacent to the embolized aneurysm in the fourth week of anticoagulation. Systemic anticoagulation of patients who have had a ruptured aneurysm treated by coil embolization may carry a significant risk of rebleeding. Alternate management strategies should be considered in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396746     DOI: 10.1007/s002340000497

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  3 in total

1.  Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion.

Authors:  M Bendszus; C Hagel; M Maurer; A Schütz; G H Vince; M C Monoranu; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 2.  Acute rerupture after coil embolization of ruptured intracranial saccular aneurysms: A literature review.

Authors:  Kailing Li; Yunbao Guo; Ying Zhao; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Interv Neuroradiol       Date:  2017-12-12       Impact factor: 1.610

3.  Rebleeding of Ruptured Intracranial Aneurysms in the Immediate Postoperative Period after Coil Embolization.

Authors:  Se Hun Chang; Hee Sup Shin; Seung Hwan Lee; Hak Cheol Koh; Jun Seok Koh
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.